|Articles|December 2, 2011

Bio-tests for Schizophrenia And Depression

The race to patent bio-tests for schizophrenia and depression: some say this initiative is destined to fail.

Recent articles by Arline Kaplan and Hagop Asiskal, MD, highlight the race to patent bio-tests for schizophrenia and depression. Dr Max Fink continues the discussion in his commentary; he contends the DSM divisions serve patients and doctors poorly. Tell us what you think.
 

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.


Latest CME